We are live on
!
Find out more
SAM
Symphony Asset Management Portfolio holdings
AUM
$309M
1-Year Est. Return
9.39%
This Fund
S&P 500
This Quarter
Est. Return
+4.08%
1 Year Est. Return
+9.39%
3 Year Est. Return
+21.56%
5 Year Est. Return
+39.45%
10 Year Est. Return
–
AUM
$988M
AUM Growth
-$49.9M
(-4.8%)
Cap. Flow
-$378M
Cap. Flow
% of AUM
-38.29%
Top 10 Holdings %
Top 10 Hldgs %
24.25%
Holding
416
New
77
Increased
92
Reduced
134
Closed
62
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$11.9M |
| 2 |
Booking.com
BKNG
|
+$4.33M |
| 3 |
ONIT
Onity Group
ONIT
|
+$4.31M |
| 4 |
Cisco
CSCO
|
+$4.25M |
| 5 |
Viavi Solutions
VIAV
|
+$3.68M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$5.47M |
| 2 |
Howard Hughes
HHH
|
+$2.84M |
| 3 |
Rayonier
RYN
|
+$2.83M |
| 4 |
Verizon
VZ
|
+$2.81M |
| 5 |
Lithia Motors
LAD
|
+$2.74M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 6.92% |
| 2 | Technology | 6.49% |
| 3 | Consumer Discretionary | 6.21% |
| 4 | Healthcare | 6.1% |
| 5 | Industrials | 5.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ASCMA
201
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
| $742K | 0.08% |
9,198
-6,992
| -43% | -$550K |
|
202
TFS Financial
TFSL
$5.1B
| $737K | 0.07% |
+61,567
| New | +$709K |
|
203
Halliburton
HAL
$27.9B
| $734K | 0.07% |
+15,248
| New | +$714K |
|
204
WEX
WEX
$6.11B
| $733K | 0.07% |
8,357
-6,113
| -42% | -$517K |
|
|
UCB
205
United Community Banks
UCB
$4.22B
| $732K | 0.07% |
+48,831
| New | +$709K |
|
206
Coca-Cola Europacific Partners
CCEP
$46.5B
| $731K | 0.07% |
18,185
-2,957
| -14% | -$113K |
|
|
WP
207
DELISTED
Worldpay, Inc.
WP
| $729K | 0.07% |
+26,096
| New | +$711K |
|
208
CoreCivic
CXW
$3.1B
| $727K | 0.07% |
+21,034
| New | +$705K |
|
|
TMH
209
DELISTED
Team Health Holdings Inc
TMH
| $719K | 0.07% |
18,963
-5,421
| -22% | -$212K |
|
|
GWR
210
DELISTED
Genesee & Wyoming Inc.
GWR
| $717K | 0.07% |
7,715
-3,463
| -31% | -$313K |
|
211
Thermo Fisher Scientific
TMO
$211B
| $714K | 0.07% |
7,747
+2,334
| +43% | +$211K |
|
|
XLNX
212
DELISTED
Xilinx Inc
XLNX
| $706K | 0.07% |
+15,064
| New | +$677K |
|
|
MRC
213
DELISTED
MRC Global
MRC
| $703K | 0.07% |
+26,228
| New | +$699K |
|
|
EXXI
214
DELISTED
ENERGY XXI LTD COM SHS
EXXI
| $700K | 0.07% |
+23,183
| New | +$622K |
|
215
Wolverine World Wide
WWW
$1.54B
| $695K | 0.07% |
23,890
-6,840
| -22% | -$195K |
|
|
FNSR
216
DELISTED
Finisar Corp
FNSR
| $695K | 0.07% |
+30,720
| New | +$633K |
|
|
PETM
217
DELISTED
PETSMART INC
PETM
| $688K | 0.07% |
9,025
+2,720
| +43% | +$197K |
|
218
Movado Group
MOV
$812M
| $685K | 0.07% |
15,658
-4,499
| -22% | -$176K |
|
219
O-I Glass
OI
$1.39B
| $680K | 0.07% |
22,652
+2,134
| +10% | +$63.3K |
|
220
Autodesk
ADSK
$44.3B
| $664K | 0.07% |
+16,128
| New | +$596K |
|
221
Helios Technologies
HLIO
$2.64B
| $653K | 0.07% |
17,979
-5,135
| -22% | -$168K |
|
222
DTE Energy
DTE
$31.1B
| $650K | 0.07% |
11,568
+1,173
| +11% | +$68K |
|
|
KRFT
223
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
| $647K | 0.07% |
12,333
-44,225
| -78% | -$2.42M |
|
224
Capital One
COF
$124B
| $638K | 0.06% |
+9,284
| New | +$625K |
|
225
Portland General Electric
POR
$6.02B
| $634K | 0.06% |
22,427
-18,597
| -45% | -$555K |
|
Similar funds
LWM
FCI
TAM
BHG
NIT
ACMV
TL
RCM
Symphony Asset Management's Q3 2013 Portfolio in Review
As of Q3 2013, Symphony Asset Management held 416 positions worth $988M, down 4.8% from $1.04B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Symphony Asset Management withdrew a net $378M in Q3 2013, closing 62 positions and reducing 134 holdings. Its most notable exit was Allergan plc, an estimated $5.47M position sold in full.
By sector, the portfolio is most concentrated in Financials at 6.9% of assets, up from 5.5% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Symphony Asset Management opened a new position in Elevance Health worth $11.6M.
- Symphony Asset Management's largest Q3 2013 buy was Elevance Health: 138,500 shares worth $11.6M.
- Symphony Asset Management added most to Booking.com in Q3 2013, an estimated $4.33M increase.
- Symphony Asset Management's biggest Q3 2013 reduction was Verizon, cutting an estimated $2.81M.
- Symphony Asset Management fully exited Allergan plc in Q3 2013, selling an estimated $5.47M.
- Symphony Asset Management's ten largest holdings make up 24% of its $988M portfolio in Q3 2013.
- Symphony Asset Management opened 77 new positions and closed 62 in Q3 2013.
- Symphony Asset Management's portfolio value fell 4.8% quarter-over-quarter to $988M.
Based on Symphony Asset Management's 13F filing for Q3 2013, filed 13 Nov 2013.